Skip to content
Menu

YD Bio Ltd YDES

Full chart Compare
Set alert

Price alert · YDES

All alert types
4.83 USD +0.27 (+5.92%)

Regular-session close

4.83 0.00 0.00%

After hours · Nov 20, 4:00 PM ET

4.36 Day range 4.95
1.90 52-week range 15.42
YTD
-60.38%
1 year
-42.22%

 

No chart data for this range yet.
Market cap
342.12M
Revenue (ttm)
510.36K
Profit margin
-276.58%
EPS (ttm)
-0.04
Shares out
70.52M
YTD return
-60.38%
1-year return
-42.22%
Volume
29.79K
Avg volume
309.31K
Open
4.80
Previous close
4.56
Day's range
4.36 – 4.95
52-week range
1.90 – 15.42
Beta
0.16

Key statistics

50-day average
17.26
200-day average
17.26
Enterprise value
19.67M
Price / sales
1829.50
Price / book
2.90
Revenue growth
95.60%
Free cash flow
-3.88M
Total cash
3.13M
Total debt
22.27K
Return on equity
-42.69%
Short % of float
0.52%

Fundamental scorecard

5 of 25 checks passed on YDES’s reported financials

ValueGrowthProfitabilityHealthDividend

5of 25 checks passed

  • Value 0 of 5
  • Growth 2 of 5
  • Profitability 0 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Jun 30, 2026.

Financials — quick view

All financials
YDES Revenue — quarterly 510.36K
YDES Net income — quarterly 1.31M
YDES EPS — quarterly 0.09

About YD Bio Ltd

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.

Sector
Healthcare
Industry
Biotechnology
Country
Taiwan

News

Your note

Sign in to keep a note on YDES — it syncs with the Stock Master app.

Institution ownership

YDES institution ownership
Holder% heldSharesValueReported
Cerity Partners LLC0.05%32,406429.06KSep 29, 2025

Fund ownership

YDES fund ownership
Holder% heldSharesValueReported
Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF0.03%20,862276.21KSep 29, 2025